Careers  |  Sign In  |  Register  |   Twitter

New Drug May Help Treat Wet Age-Related Macular Degeneration

According to Reuters, a new drug developed by Avalanche Biotechnologies Inc. has successfully completed a mid stage study. The drug, AVA-101, is used to treat patients with wet age-related macular degeneration and is effective in improving vision when compared to the placebo. Wet age-related macular degeneration typically occurs in people older than 50 and can lead to a loss of vision, particularly visual acuity and central vision that enables people to see straight ahead. Further studies on AVA-101 will be continuing into the future.

 

Read the article on Reuters.

Read the clinical trial on ClinicalTrials.gov.